CGT Global Blog

CGT Global News

Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.

Peripheral Blood Mononuclear Cells: A Brief Review

January 9, 2019

Peripheral blood mononuclear cells (PBMCs) are a diverse mixture of highly specialized immune cells that play key roles in keeping our bodies healthy. This brief review tells a short story about PBMCs starting with their origin, the different immune cells within the PBMC fraction, isolation of these cells and how to characterize them, and once isolated and characterized, how these cells benefit medical research. By Tera Muir, PhD. Origin of Peripheral Blood Mononuclear Cells The Frequency of Different Cell Populations within the…

Early Detection of Cancer from a Single Blood Draw

December 17, 2018

How can a single blood draw detect cancer early in disease progression? The National Cancer Institute estimates 1,735,350 new cases of cancers with mortality exceeding 600,000 this year in the US alone. It is therefore imperative to find an early detection system and effective treatment of these cancers to help ease the mortality rate. Early detection refers to measures that can be taken to diagnose cancer as early as possible when the disease is easiest to treat. These measures include annual screens such…

MEA’S STORY

December 14, 2018

My life changed on May 6, 2006 I remember leaving my house to go shopping. Like many times before, I was driving on the highway and listening to music. After that my next memory is waking up in the emergency room. When I opened my eyes, I remember my family and friends looking down at me crying. When I tried to speak I was unable to form a complete sentence. I started to cry. I had no idea how I had ended…

San Diego Stem Cell Collection Center Open House: 12/3/18

November 27, 2018

YOU’RE INVITED StemExpress is having an open house for our San Diego Stem Cell Collection Center! We are a life-science company dedicated to supporting researchers globally by providing high-quality human biospecimens including peripheral blood, T-cells and Leukopaks® – and it all starts at our collection center. WHEN: Monday, 12/3      TIME: 12 pm – 5 pm     WHERE: 4520 Executive Drive, Suite 350 | San Diego, CA 92121   [button title=”RSVP here” link=”https://events.r20.constantcontact.com/register/eventReg?oeidk=a07efsuk8fie5c28fb6&oseq=&c=&ch=” target=”_blank” align=”” icon=”” icon_position=”” color=”blue” font_color=”white” size=”2″ full_width=”” class=”” download=”” rel=”” onclick=””]…

CGT Global Exhibiting at the 60th ASH Annual Meeting & Exposition

November 13, 2018

ABOUT THE EVENT Attend the world’s most comprehensive hematology event of the year, the 60th ASH Annual Meeting and Exposition in sunny San Diego. The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field and a global community of more than 25,000 hematology professionals from every subspecialty. TO LEARN MORE, CLICK HERE

CGT Global Partners with Biological Industries

October 30, 2018

StemExpress partners with Biological Industries USA regarding the non-exclusive global distribution of our well-defined high-quality Mesenchymal Stem Cells (MSCs). With the addition of our MSCs, Biological Industries, a leading cell culture media developer and manufacturer, now offers a full cell culture solution to their clients. Using Biological Industries’ NutriStem® MSC Medium, a completely defined serum-free, xeno-free, low-protein formula medium, in combination with StemExpress’ MSCs researchers and clinicians can produce clinical-quality MSCs for their research needs. Check out their latest Application Note and see how…

CGT Global Exhibiting at NIH: Research Festival Exhibit

October 5, 2018

ABOUT THE EVENT The NIH mission is to expand fundamental knowledge about the nature and behavior of living systems and to improve and develop new strategies for the diagnosis, treatment, and prevention of disease and communicate the results of research with the goal of improving health. NIH works toward that mission by conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of…

New Valley Vision Board Member – Cate Dyer

September 6, 2018

New Valley Vision Board Member – Cate Dyer It’s an exciting day here at StemExpress! Our CEO, Cate Dyer, is now part of Valley Visions volunteer board. Valley Vision is a civic leadership organization that works together to improve Sacramento regional communities. They take on the most persistent economic, social, and environmental challenges our communities face and find solutions to build strong communities, a healthy environment, and a vital economy. We know our fearless leader will be a valuable member of the…

CGT Global Exhibiting at CAR-TCR Summit 2018

August 23, 2018

ABOUT THE EVENT Welcome to the 4th Annual CAR-TCR Summit 2018 Changing Lives with CAR-T & TCR Cell Immunotherapies The CAR-TCR Summit is the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies for solid tumor indications, whilst ensuring the accessibility and commercial delivery of currently approved life-changing CAR-TCR therapies to patients around the world. TO LEARN MORE, CLICK HERE.

Why use Clinical Grade Non-Transfusable products?

August 21, 2018

Why use Clinical Grade Non-Transfusable products? Within the last year, progress in cellular therapies have led to the restoration of eyesight, construction of new skin, a cure for sickle-cell, and the FDA approval of cancer-killing CAR-T cells, and it’s set to advance even further. However, these types of therapies can be hindered by the cost and time to develop. With some taking over 7 years and $2.5 billion to find their way to the FDA approval process, these new therapies may not…

New Clinical Grade Non-Transfusable Products

August 21, 2018

[vc_row][vc_column][vc_column_text] New Clinical Grade Non-Transfusable Products StemExpress, a Folsom CA-based leading supplier of human biospecimens, announces the release of Clinical Grade Non-Transfusable products to customers developing studies relating to transplantation, cell therapy, regenerative medicine, investigational new drug (IND) development, and the research and development (R&D) of medical devices in preclinical and clinical phases. The NEW Clinical Grade Non-Transfusable Products support a smooth transition from laboratory prototype to commercial production. The new product line features: Clinical Grade Non-Transfusable Bone Marrow Clinical Grade Non-Transfusable…

Fresh or Frozen Primary Cells: Helpful tips for choosing the right format for your research.

July 31, 2018

Fresh or Frozen Primary Cells: Which one should I choose? Deciding to purchase fresh or frozen primary cells may not be as simple as you think. There are many factors that may influence your decision, such as cell type, cell functionality, and logistical and timing flexibility. We hope that the following article provides the information you require to make a decision in choosing fresh or frozen primary cells for your specific research.   Fresh Cells At StemExpress, fresh cells are offered as…